| Pharmaceutical active ingredients: |
| Tirofiban Hydrochloride |
| Available forms, composition and doses of Aggrastet: |
| Injectable; Infusion; Tirofiban Hydrochloride 0.05 mg / mlInjectable; Infusion; Tirofiban Hydrochloride 0.25 mg / ml |
| Aggrastet medical category: |
| Human:Anticoagulants, antiplatelets and fibrinolytics (thrombolytics)Platelet aggregation inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| B01AC17 - Tirofiban |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Merck |
| Related documents and information about Aggrastet: |
| Aggrastat prescribing information (PDF) |